Matrix Metalloproteinase 19 Regulates Insulin-like Growth Factor-mediated Proliferation, Migration, and Adhesion in Human Keratinocytes through Proteolysis of Insulin-like Growth Factor Binding Protein-3

Molecular Biology of the Cell

Volumn 14, Issue 11, 2003, Pages 4569-4580

  Sadowski, Thorsten ^a   Dietrich, Sebastian ^a   Koschinsky, Felix ^a   Sedlacek, Radislav ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 19; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL ADHESION; CELL CONTACT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DOWN REGULATION; ENZYME INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CADHERINS; CALCIUM; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CLONING, MOLECULAR; COLLAGEN TYPE I; DOWN-REGULATION; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; METALLOENDOPEPTIDASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 0345255740     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-01-0009     Document Type: Article

References (61)

1. Ando, Y., and Jensen, P.J. (1993). Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J. Investig. Dermatol. 100, 633-639.
2. Baron, V., Calleja, V., Ferrari, P., Alengrin, F., and van Obberghen, E. (1998). p125FAK focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tryrosine kinase receptors. J. Biol. Chem. 273, 7162-7168.
3. Bikle, D.D., and Pillai, S. (1993). Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 14, 3-19.
4. Birkedahl-Hansen, H., Moore, W.G., Bodden, M.-K., Windsor, L.J., Birkedahl-Hansen, B., DeCarlo, A., and Engler, J.-A. (1993). Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197
5. Brabletz, T., Jung, A., Dag, S., Hlubek, F., and Kirchner, T. (1999). beta-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155, 1033-1038.
6. Brooks, P.C., Klemke, R.L., Schoen, S., Lewis, J.M., Schwartz, M.A., and Cheresh, D.A. (1997). Insulin-like growth factor receptor cooperates with integrin αVβ5 to promote tumor cell dissemination in vivo. J. Clin. Investig. 99, 1390-1398.
7. Buisson-Legendre, N., Bernard, P., Bobichon, H., Emonard, H., Schneider, C., Maquart, F.X., Haye, B., and Homebeck, W. (1999). Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. Biochem. Biophys. Res. Commun. 260, 634-640.
8. Cohen, P., Graves, H.C., Peehl, D.M., Kamarei, M., Guidice, L.C., and Rosenfeld, R.G. (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75, 1046-1053.
9. Conover, C.A., and De Leon, D.D. (1994). Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J. Biol. Chem. 269, 7076-7080.
10. Crawford, H.C., Fingleton, B.M., Rudolph-Owen, L.A., Goss, K.J., Rubinfeld, B., Polakis, P., and Matrisian, L.M. (1999). The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18, 2883-2891.
11. Doerr, M.E., and Jones, J.I. (1996). The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271, 2443-2447.
12. Edmondson, S.R., Werther, G.A., and Wraight, C.J. (2001). Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT. J. Investig. Dermatol. 116, 491-497.
13. Fowlkes, J.L., Enghild, J.J., Suzuki, K., and Nagase, H. (1994). Matrix metalloproteinases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269, 25742-25746.
14. Hangauer, D.G., Monzingo, A.F., and Matthews, B.W. (1984). An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. Biochemistry 23, 5730-5741.
15. Hermanto, U., Zong, C.S., Li, W., and Wang, L.H. (2002). RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol. Cell. Biol. 22, 2345-2365.
16. Ho, A.T., Voura, E.B., Soloway, P.D., Watson, K.L.M., and Khokha, R. (2001). MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function. J. Biol. Chem. 276, 40215-40224.
17. Hodivala, K.J., and Watt, F.M. (1994). Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J. Cell Biol. 124, 589-600.
18. Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., and Yamamoto, T. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
19. Impola, U., Toriseva, M., Suomela, S., Jeskanen, L., Hieta, N., Jahkola, T., Grenman, R., Kahari, V.M., and Saarialho-Kere, U. (2003). Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int. J. Cancer 103, 709-716.
20. Kobayashi, T., Onoda, N., Takagi, T., Hori, H., Hattori, S., Nagai, Y., Tajima, S., and Nishikawa, T. (1996). Immunolocalizations of human gelatinase (type IV collagenase, MMP-9) and TIMP (tissue inhibitor of metalloproteinases) in normal epidermis and some epidermal tumors. Arch. Dermatol. Res. 288, 239-244.
21. Koshizuka, S., Kanazawa, K., Kobayashi, N., Takazawa, I., Waki, Y., Shibusawa, H., and Shumiya, S. (1997). The beneficial effects of recombinant human insulin-like growth factor-I (IGF-I) on wound healing in severely wounded senescent mice. Surg. Today 27, 946-952.
22. Krane, J.F., Gottlieb, A.B., Carter, D.M., and Krueger, J.G. (1992). The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J. Exp. Med. 175, 1081-1090.
23. Lewis, J.E., Jensen, P.J., and Wheelock, M.J. (1994). Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J. Investig. Dermatol. 102, 870-877.
24. Lohi, J., Wilson, C.L., Roby, J.D., and Parks, W.C. (2001). Epilysin. A novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem. 276, 10134-10144.
25. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J., and Efstratiadis, A. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r). Cell 75, 59-72.
26. Lund, L.R., Rømer, J. Bugge, T.H., Nielsen, B.S., Frandsen, T.L., Degen, J.L., Stephens, R.W., and Danø, K. (1999). Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18, 4645-4656.
27. Manes, S., Llorente, M., Lacalle, R.A., Gomez-Mouton, C., Kremer, L., Mira, E., and Martinez-A., C. (1999a). The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in D.U-145 carcinoma cells. J. Biol. Chem. 274, 6935-6945.
28. Manes, S., Mira, E., Gomez-Mouton, C., Zhao, Z.J., Lacalle, R.A., and Martinez-A. C. (1999b). Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19, 3125-3135.
29. Mauch, S., Kolb, C., Kolb, B., Sadowski, T., and Sedlacek, R. (2002). Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J. Immunol. 168, 1244-1251.
30. McCusker, R.H., Busby, W.H., Dehoff, M.H., Camacho-Hubner, C., and Clemmons, D.R. (1991). Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 129, 939-949.
31. Mira, E., Manes, S., Lacalle, R.A., Marquez, G., and Martinez-A, C. (1999). Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9. Endocrinology 140, 1657-1664.
32. Miyamoto, S., Teramoto, H., Coso, O., Gutkind, J., Burbelo, P., Akiyama, S., and Yamada, K. (1995). Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131, 791-805.
33. Mohan, R. et al. (2002). Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 277, 2065-2072.
34. Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., and Tryggvason, K. (1999). Structure of human pro-matrix metalloproteinase-2, activation mechanism revealed. Science 284, 1667-1670.
35. Mueller, M.S., Mauch, S., Kolb, C., Kusch, J., Sadowski, T., and Sedlacek, R. (2000). The murine ortholog of matrix metalloproteinase 19, its cloning, gene organization, and expression. Gene 256, 101-111.
36. Munshi, H.G., Wu, Y.I., Ariztia, E.V., and Stack, M.S. (2002). Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. J. Biol. Chem. 277, 41480-41488.
37. Oda, Y., Tu, C.L., Pillai, S., and Bikle, D.D. (1998). The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J. Biol. Chem. 273, 23344-23352.
38. Oh, Y. (1997). IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine 7, 111-113.
39. Oliver, M.H., Harrison, N.K., Bishop, J.E., Cole, P.J., and Laurent, G.J. (1989). A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92, 513-518.
40. Palecek, S.P., Loftus, J.C., Ginsberg, M.H., Lauffenburger, D.A., and Horwitz, A.F. (1997). Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385, 537-540.
41. Paramio, J.M., and Jorcano, J.L. (1997). Role of protein kinases in the in vitro differentiation of human epidermal HaCaT cells. Br. J. Dermatol. 137, 44-50.
42. Parks, W.C., and Mecham, R.P. (eds) (1998) Matrix Metalloproteinases, San Diego: Academic Press.
43. Pece, S., and Gutkind, J.S. (2000). Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem. 275, 41227-41233.
44. Pilcher, B.K., Dumin, J.A., Sudbek, B.D., Krane, S.M., Welgus, H.G., and Parks, W.C. (1997). The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137, 1445-1457.
45. Pilcher, B.K., Wang, M., Qin, X.J., Parks, W.C., Senior, R.M., and Welgus, H.G. (1999). Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann. N.Y. Acad. Sci. 878, 12-24.
46. Rudman, S.M., Philpott, M.P., Thomas, G.A., and Kealey, T. (1997). The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J. Investig. Dermatol. 109, 770-777.
47. Saarialho-Kere, U.K., Kovacs, S.O., Pentland, A.P., Olerud, J.E., Welgus, H.G., and Parks, W.C. (1993). Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J. Clin. Investig. 92, 2858-2866.
48. Saarialho-Kere, U.K., Pentland, A.P., Birkedal-Hansen, H., Parks, W.C., and Welgus, H.G. (1994). Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Investig. 94, 79-88.
49. Saarialho-Kere, U.K., Kerkelä, E., Jahkola, T., Suomela, S., Keski-Oja, J., and Lohi, J. (2002). Epilysin (MMP-28) expression is associated with cell prolifer ation during epithelial repair. J. Investig. Dermatol. 199, 14-21.
50. Sadowski, T., Dietrich, S., Mueller, M., Havlickova, B., Schunck, M., Proksch, E., Mueller, M.S., and Sedlacek, R. (2003) MMP-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. J. Investig. Dermatol. (in press).
51. Schwartz, M., Schaller, M., and Ginsberg, M. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell. Dev. Biol. 11, 549-599.
52. Shakibaei, M., John, T., De Souza, P., Rahmanzadeh, R., and Merker, H.J. (1999). Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem. J. 342 Pt 3, 615-623.
53. Shimasaki, S., and Ling, N. (1991). Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3, 243-266.
54. Suomela, S., Kariniemi, A., Impola, U., Karvonen, S.L., Snellman, E., Uurasmaa, T., Peltonen, J., and Saarialho-Kere, U. (2003). Matrix Metalloproteinase-19 is expressed by keratinocytes in psoriasis. Acta Derm. Venereol. 83, 108-114.
55. St. Croix, B., Sheehan, C., Rak, J.W., Florenes, V.A., Slingerland, J.M., and Kerbel, R.S. (1998). E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell Biol. 142, 557-571.
56. Stracke, J.O., Hutton, M., Stewart, M., Pendás, A.M., Smith, B., López-Otín, C., Murphy, G., Knäuper, V. (2000).). Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J. Biol. Chem. 275, 14809-14816.
57. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K.M. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617.
58. Tavakkol, A., Elder, J.T., Griffiths, C.E.M., Cooper, K.D., Talwar, H., Fisher, G.J., Keane, K.M., Foltin, S.K., and Voorhees, J.J. (1992). Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J. Invest. Dermatol. 99, 343-349.
59. Todd, C., and Reynolds, N.J. (1998). Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am. J. Pathol. 153, 39-45.
60. Vu, T.H., and Werb, Z. (2000). Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123
61. Wraight, C.J., Edmondson, S.R., Fortune, D.W., Varigos, G., and Werther, G.A. (1997). Expression of insulin-like growth factor binding protein-3 (IG-FBP-3) in the psoriatic lesion. J. Investig. Dermatol. 108, 452-456.